nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrabenazine—DRD2—Bromocriptine—type 2 diabetes mellitus	0.168	0.358	CbGbCtD
Tetrabenazine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0883	0.188	CbGbCtD
Tetrabenazine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0815	0.174	CbGbCtD
Tetrabenazine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0669	0.143	CbGbCtD
Tetrabenazine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0641	0.137	CbGbCtD
Tetrabenazine—Donepezil—CYP3A4—type 2 diabetes mellitus	0.00151	1	CrCbGaD
Tetrabenazine—CBR1—islet of Langerhans—type 2 diabetes mellitus	0.0013	0.13	CbGeAlD
Tetrabenazine—DRD2—nerve—type 2 diabetes mellitus	0.00128	0.129	CbGeAlD
Tetrabenazine—CBR1—nephron tubule—type 2 diabetes mellitus	0.00105	0.105	CbGeAlD
Tetrabenazine—CBR1—cardiovascular system—type 2 diabetes mellitus	0.000941	0.0943	CbGeAlD
Tetrabenazine—CBR1—kidney—type 2 diabetes mellitus	0.00092	0.0922	CbGeAlD
Tetrabenazine—CBR1—cortex of kidney—type 2 diabetes mellitus	0.000896	0.0898	CbGeAlD
Tetrabenazine—CBR1—adipose tissue—type 2 diabetes mellitus	0.000829	0.0831	CbGeAlD
Tetrabenazine—SLC18A2—adipose tissue—type 2 diabetes mellitus	0.000713	0.0715	CbGeAlD
Tetrabenazine—Nausea—Nateglinide—type 2 diabetes mellitus	0.000644	0.00184	CcSEcCtD
Tetrabenazine—Cardiac disorder—Valsartan—type 2 diabetes mellitus	0.000644	0.00184	CcSEcCtD
Tetrabenazine—Bradycardia—Metformin—type 2 diabetes mellitus	0.000643	0.00184	CcSEcCtD
Tetrabenazine—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.000642	0.00183	CcSEcCtD
Tetrabenazine—Diarrhoea—Repaglinide—type 2 diabetes mellitus	0.000642	0.00183	CcSEcCtD
Tetrabenazine—Fatigue—Pioglitazone—type 2 diabetes mellitus	0.000641	0.00183	CcSEcCtD
Tetrabenazine—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000641	0.00183	CcSEcCtD
Tetrabenazine—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000639	0.00183	CcSEcCtD
Tetrabenazine—Nervousness—Gliclazide—type 2 diabetes mellitus	0.000638	0.00182	CcSEcCtD
Tetrabenazine—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000636	0.00182	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Ramipril—type 2 diabetes mellitus	0.000635	0.00182	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Ramipril—type 2 diabetes mellitus	0.000635	0.00182	CcSEcCtD
Tetrabenazine—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000634	0.00181	CcSEcCtD
Tetrabenazine—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000629	0.0018	CcSEcCtD
Tetrabenazine—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000629	0.0018	CcSEcCtD
Tetrabenazine—Breast disorder—Ramipril—type 2 diabetes mellitus	0.000628	0.0018	CcSEcCtD
Tetrabenazine—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000627	0.00179	CcSEcCtD
Tetrabenazine—Fatigue—Glimepiride—type 2 diabetes mellitus	0.000624	0.00179	CcSEcCtD
Tetrabenazine—Fatigue—Sitagliptin—type 2 diabetes mellitus	0.000622	0.00178	CcSEcCtD
Tetrabenazine—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000617	0.00176	CcSEcCtD
Tetrabenazine—Tremor—Gliclazide—type 2 diabetes mellitus	0.000616	0.00176	CcSEcCtD
Tetrabenazine—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000613	0.00175	CcSEcCtD
Tetrabenazine—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.00061	0.00175	CcSEcCtD
Tetrabenazine—Mental disorder—Valsartan—type 2 diabetes mellitus	0.000607	0.00174	CcSEcCtD
Tetrabenazine—Bradycardia—Irbesartan—type 2 diabetes mellitus	0.000607	0.00173	CcSEcCtD
Tetrabenazine—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000606	0.00173	CcSEcCtD
Tetrabenazine—Agitation—Gliclazide—type 2 diabetes mellitus	0.000604	0.00173	CcSEcCtD
Tetrabenazine—Confusional state—Glyburide—type 2 diabetes mellitus	0.000602	0.00172	CcSEcCtD
Tetrabenazine—Dysphagia—Ramipril—type 2 diabetes mellitus	0.000601	0.00172	CcSEcCtD
Tetrabenazine—Mental disorder—Orlistat—type 2 diabetes mellitus	0.0006	0.00172	CcSEcCtD
Tetrabenazine—Sweating—Losartan—type 2 diabetes mellitus	0.000599	0.00171	CcSEcCtD
Tetrabenazine—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000597	0.00171	CcSEcCtD
Tetrabenazine—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000596	0.00171	CcSEcCtD
Tetrabenazine—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000595	0.0017	CcSEcCtD
Tetrabenazine—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.000591	0.00169	CcSEcCtD
Tetrabenazine—Eye disorder—Metformin—type 2 diabetes mellitus	0.00059	0.00169	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.000588	0.00168	CcSEcCtD
Tetrabenazine—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000588	0.00168	CcSEcCtD
Tetrabenazine—Headache—Repaglinide—type 2 diabetes mellitus	0.000587	0.00168	CcSEcCtD
Tetrabenazine—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000586	0.00168	CcSEcCtD
Tetrabenazine—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.000586	0.00168	CcSEcCtD
Tetrabenazine—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000586	0.00167	CcSEcCtD
Tetrabenazine—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000584	0.00167	CcSEcCtD
Tetrabenazine—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000582	0.00167	CcSEcCtD
Tetrabenazine—CBR1—liver—type 2 diabetes mellitus	0.000582	0.0583	CbGeAlD
Tetrabenazine—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.000581	0.00166	CcSEcCtD
Tetrabenazine—Bronchitis—Ramipril—type 2 diabetes mellitus	0.000578	0.00165	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Glyburide—type 2 diabetes mellitus	0.000577	0.00165	CcSEcCtD
Tetrabenazine—Angiopathy—Metformin—type 2 diabetes mellitus	0.000573	0.00164	CcSEcCtD
Tetrabenazine—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000568	0.00162	CcSEcCtD
Tetrabenazine—Fatigue—Bromocriptine—type 2 diabetes mellitus	0.000563	0.00161	CcSEcCtD
Tetrabenazine—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000559	0.0016	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.000558	0.0016	CcSEcCtD
Tetrabenazine—Hypotension—Glyburide—type 2 diabetes mellitus	0.000558	0.0016	CcSEcCtD
Tetrabenazine—Anxiety—Gliclazide—type 2 diabetes mellitus	0.000557	0.00159	CcSEcCtD
Tetrabenazine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000557	0.00159	CcSEcCtD
Tetrabenazine—Asthenia—Glipizide—type 2 diabetes mellitus	0.000557	0.00159	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000555	0.00159	CcSEcCtD
Tetrabenazine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000555	0.00159	CcSEcCtD
Tetrabenazine—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000553	0.00158	CcSEcCtD
Tetrabenazine—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000547	0.00156	CcSEcCtD
Tetrabenazine—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000541	0.00155	CcSEcCtD
Tetrabenazine—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000541	0.00155	CcSEcCtD
Tetrabenazine—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000538	0.00154	CcSEcCtD
Tetrabenazine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000533	0.00153	CcSEcCtD
Tetrabenazine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000532	0.00152	CcSEcCtD
Tetrabenazine—DRD2—retina—type 2 diabetes mellitus	0.000531	0.0533	CbGeAlD
Tetrabenazine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000531	0.00152	CcSEcCtD
Tetrabenazine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000526	0.00151	CcSEcCtD
Tetrabenazine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000526	0.0015	CcSEcCtD
Tetrabenazine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000521	0.00149	CcSEcCtD
Tetrabenazine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00052	0.00149	CcSEcCtD
Tetrabenazine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000519	0.00148	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Gliclazide—type 2 diabetes mellitus	0.000518	0.00148	CcSEcCtD
Tetrabenazine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000518	0.00148	CcSEcCtD
Tetrabenazine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000516	0.00148	CcSEcCtD
Tetrabenazine—Tremor—Metformin—type 2 diabetes mellitus	0.000515	0.00147	CcSEcCtD
Tetrabenazine—Sweating—Ramipril—type 2 diabetes mellitus	0.000514	0.00147	CcSEcCtD
Tetrabenazine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000513	0.00147	CcSEcCtD
Tetrabenazine—Anxiety—Valsartan—type 2 diabetes mellitus	0.000512	0.00146	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.00051	0.00146	CcSEcCtD
Tetrabenazine—Tension—Irbesartan—type 2 diabetes mellitus	0.000509	0.00146	CcSEcCtD
Tetrabenazine—Angiopathy—Losartan—type 2 diabetes mellitus	0.000509	0.00145	CcSEcCtD
Tetrabenazine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000509	0.00145	CcSEcCtD
Tetrabenazine—Anxiety—Orlistat—type 2 diabetes mellitus	0.000506	0.00145	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000504	0.00144	CcSEcCtD
Tetrabenazine—Nervousness—Irbesartan—type 2 diabetes mellitus	0.000504	0.00144	CcSEcCtD
Tetrabenazine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000503	0.00144	CcSEcCtD
Tetrabenazine—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000501	0.00143	CcSEcCtD
Tetrabenazine—SLC18A2—liver—type 2 diabetes mellitus	0.0005	0.0501	CbGeAlD
Tetrabenazine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000497	0.00142	CcSEcCtD
Tetrabenazine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000495	0.00142	CcSEcCtD
Tetrabenazine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000494	0.00141	CcSEcCtD
Tetrabenazine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000493	0.00141	CcSEcCtD
Tetrabenazine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000492	0.00141	CcSEcCtD
Tetrabenazine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000492	0.00141	CcSEcCtD
Tetrabenazine—Headache—Glipizide—type 2 diabetes mellitus	0.000486	0.00139	CcSEcCtD
Tetrabenazine—Tremor—Irbesartan—type 2 diabetes mellitus	0.000486	0.00139	CcSEcCtD
Tetrabenazine—Insomnia—Gliclazide—type 2 diabetes mellitus	0.000485	0.00139	CcSEcCtD
Tetrabenazine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000483	0.00138	CcSEcCtD
Tetrabenazine—Tension—Losartan—type 2 diabetes mellitus	0.000479	0.00137	CcSEcCtD
Tetrabenazine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000479	0.00137	CcSEcCtD
Tetrabenazine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000479	0.00137	CcSEcCtD
Tetrabenazine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000478	0.00137	CcSEcCtD
Tetrabenazine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000477	0.00137	CcSEcCtD
Tetrabenazine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000477	0.00136	CcSEcCtD
Tetrabenazine—Agitation—Irbesartan—type 2 diabetes mellitus	0.000477	0.00136	CcSEcCtD
Tetrabenazine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000477	0.00136	CcSEcCtD
Tetrabenazine—Nervousness—Losartan—type 2 diabetes mellitus	0.000474	0.00136	CcSEcCtD
Tetrabenazine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000473	0.00135	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	0.000471	0.00135	CcSEcCtD
Tetrabenazine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000469	0.00134	CcSEcCtD
Tetrabenazine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000466	0.00133	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000465	0.00133	CcSEcCtD
Tetrabenazine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000464	0.00133	CcSEcCtD
Tetrabenazine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000462	0.00132	CcSEcCtD
Tetrabenazine—Nausea—Glipizide—type 2 diabetes mellitus	0.000461	0.00132	CcSEcCtD
Tetrabenazine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00046	0.00132	CcSEcCtD
Tetrabenazine—Hypotension—Valsartan—type 2 diabetes mellitus	0.00046	0.00132	CcSEcCtD
Tetrabenazine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000459	0.00131	CcSEcCtD
Tetrabenazine—Constipation—Gliclazide—type 2 diabetes mellitus	0.000459	0.00131	CcSEcCtD
Tetrabenazine—Tremor—Losartan—type 2 diabetes mellitus	0.000457	0.00131	CcSEcCtD
Tetrabenazine—Headache—Glimepiride—type 2 diabetes mellitus	0.000454	0.0013	CcSEcCtD
Tetrabenazine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000452	0.00129	CcSEcCtD
Tetrabenazine—Agitation—Losartan—type 2 diabetes mellitus	0.000449	0.00128	CcSEcCtD
Tetrabenazine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000447	0.00128	CcSEcCtD
Tetrabenazine—Insomnia—Valsartan—type 2 diabetes mellitus	0.000446	0.00127	CcSEcCtD
Tetrabenazine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000442	0.00126	CcSEcCtD
Tetrabenazine—Insomnia—Orlistat—type 2 diabetes mellitus	0.00044	0.00126	CcSEcCtD
Tetrabenazine—Anxiety—Irbesartan—type 2 diabetes mellitus	0.00044	0.00126	CcSEcCtD
Tetrabenazine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.00044	0.00126	CcSEcCtD
Tetrabenazine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000439	0.00126	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000439	0.00125	CcSEcCtD
Tetrabenazine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000438	0.00125	CcSEcCtD
Tetrabenazine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000437	0.00125	CcSEcCtD
Tetrabenazine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000436	0.00125	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Metformin—type 2 diabetes mellitus	0.000434	0.00124	CcSEcCtD
Tetrabenazine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000432	0.00124	CcSEcCtD
Tetrabenazine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000432	0.00124	CcSEcCtD
Tetrabenazine—Nausea—Glimepiride—type 2 diabetes mellitus	0.00043	0.00123	CcSEcCtD
Tetrabenazine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000429	0.00123	CcSEcCtD
Tetrabenazine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000428	0.00123	CcSEcCtD
Tetrabenazine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000428	0.00122	CcSEcCtD
Tetrabenazine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000425	0.00121	CcSEcCtD
Tetrabenazine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000424	0.00121	CcSEcCtD
Tetrabenazine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000423	0.00121	CcSEcCtD
Tetrabenazine—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000421	0.0012	CcSEcCtD
Tetrabenazine—Constipation—Valsartan—type 2 diabetes mellitus	0.000421	0.0012	CcSEcCtD
Tetrabenazine—Fatigue—Orlistat—type 2 diabetes mellitus	0.00042	0.0012	CcSEcCtD
Tetrabenazine—Hypotension—Metformin—type 2 diabetes mellitus	0.000419	0.0012	CcSEcCtD
Tetrabenazine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000415	0.00119	CcSEcCtD
Tetrabenazine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000415	0.00119	CcSEcCtD
Tetrabenazine—Anxiety—Losartan—type 2 diabetes mellitus	0.000414	0.00118	CcSEcCtD
Tetrabenazine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000411	0.00118	CcSEcCtD
Tetrabenazine—Tension—Ramipril—type 2 diabetes mellitus	0.000411	0.00117	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	0.000409	0.00117	CcSEcCtD
Tetrabenazine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000409	0.00117	CcSEcCtD
Tetrabenazine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000409	0.00117	CcSEcCtD
Tetrabenazine—Nervousness—Ramipril—type 2 diabetes mellitus	0.000407	0.00116	CcSEcCtD
Tetrabenazine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000406	0.00116	CcSEcCtD
Tetrabenazine—Confusional state—Losartan—type 2 diabetes mellitus	0.000402	0.00115	CcSEcCtD
Tetrabenazine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000401	0.00115	CcSEcCtD
Tetrabenazine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.0004	0.00114	CcSEcCtD
Tetrabenazine—Somnolence—Metformin—type 2 diabetes mellitus	0.000399	0.00114	CcSEcCtD
Tetrabenazine—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000396	0.00113	CcSEcCtD
Tetrabenazine—Tremor—Ramipril—type 2 diabetes mellitus	0.000392	0.00112	CcSEcCtD
Tetrabenazine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000391	0.00112	CcSEcCtD
Tetrabenazine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.00039	0.00112	CcSEcCtD
Tetrabenazine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000388	0.00111	CcSEcCtD
Tetrabenazine—Fatigue—Metformin—type 2 diabetes mellitus	0.000387	0.00111	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Losartan—type 2 diabetes mellitus	0.000385	0.0011	CcSEcCtD
Tetrabenazine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000385	0.0011	CcSEcCtD
Tetrabenazine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000385	0.0011	CcSEcCtD
Tetrabenazine—Agitation—Ramipril—type 2 diabetes mellitus	0.000385	0.0011	CcSEcCtD
Tetrabenazine—Constipation—Metformin—type 2 diabetes mellitus	0.000384	0.0011	CcSEcCtD
Tetrabenazine—Vomiting—Glyburide—type 2 diabetes mellitus	0.00038	0.00109	CcSEcCtD
Tetrabenazine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000377	0.00108	CcSEcCtD
Tetrabenazine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000376	0.00108	CcSEcCtD
Tetrabenazine—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000375	0.00107	CcSEcCtD
Tetrabenazine—Headache—Glyburide—type 2 diabetes mellitus	0.000374	0.00107	CcSEcCtD
Tetrabenazine—Hypotension—Losartan—type 2 diabetes mellitus	0.000372	0.00106	CcSEcCtD
Tetrabenazine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00037	0.00106	CcSEcCtD
Tetrabenazine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000368	0.00105	CcSEcCtD
Tetrabenazine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000367	0.00105	CcSEcCtD
Tetrabenazine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000365	0.00104	CcSEcCtD
Tetrabenazine—Constipation—Irbesartan—type 2 diabetes mellitus	0.000362	0.00104	CcSEcCtD
Tetrabenazine—Insomnia—Losartan—type 2 diabetes mellitus	0.00036	0.00103	CcSEcCtD
Tetrabenazine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000355	0.00102	CcSEcCtD
Tetrabenazine—Anxiety—Ramipril—type 2 diabetes mellitus	0.000355	0.00102	CcSEcCtD
Tetrabenazine—Nausea—Glyburide—type 2 diabetes mellitus	0.000355	0.00101	CcSEcCtD
Tetrabenazine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000355	0.00101	CcSEcCtD
Tetrabenazine—Somnolence—Losartan—type 2 diabetes mellitus	0.000354	0.00101	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000354	0.00101	CcSEcCtD
Tetrabenazine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000353	0.00101	CcSEcCtD
Tetrabenazine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000349	0.000999	CcSEcCtD
Tetrabenazine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000349	0.000998	CcSEcCtD
Tetrabenazine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000349	0.000997	CcSEcCtD
Tetrabenazine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000346	0.00099	CcSEcCtD
Tetrabenazine—Confusional state—Ramipril—type 2 diabetes mellitus	0.000344	0.000985	CcSEcCtD
Tetrabenazine—Fatigue—Losartan—type 2 diabetes mellitus	0.000343	0.000982	CcSEcCtD
Tetrabenazine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000341	0.000975	CcSEcCtD
Tetrabenazine—Constipation—Losartan—type 2 diabetes mellitus	0.000341	0.000974	CcSEcCtD
Tetrabenazine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000337	0.000964	CcSEcCtD
Tetrabenazine—Headache—Gliclazide—type 2 diabetes mellitus	0.000336	0.000961	CcSEcCtD
Tetrabenazine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000335	0.000958	CcSEcCtD
Tetrabenazine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000335	0.000957	CcSEcCtD
Tetrabenazine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000333	0.000952	CcSEcCtD
Tetrabenazine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000332	0.000949	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	0.00033	0.000944	CcSEcCtD
Tetrabenazine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000328	0.000939	CcSEcCtD
Tetrabenazine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000326	0.000932	CcSEcCtD
Tetrabenazine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000322	0.00092	CcSEcCtD
Tetrabenazine—Asthenia—Metformin—type 2 diabetes mellitus	0.000322	0.00092	CcSEcCtD
Tetrabenazine—Hypotension—Ramipril—type 2 diabetes mellitus	0.000319	0.000913	CcSEcCtD
Tetrabenazine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000318	0.000911	CcSEcCtD
Tetrabenazine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000315	0.000901	CcSEcCtD
Tetrabenazine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000313	0.000896	CcSEcCtD
Tetrabenazine—Vomiting—Orlistat—type 2 diabetes mellitus	0.00031	0.000885	CcSEcCtD
Tetrabenazine—Insomnia—Ramipril—type 2 diabetes mellitus	0.000309	0.000884	CcSEcCtD
Tetrabenazine—Headache—Valsartan—type 2 diabetes mellitus	0.000309	0.000883	CcSEcCtD
Tetrabenazine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000307	0.000878	CcSEcCtD
Tetrabenazine—Headache—Orlistat—type 2 diabetes mellitus	0.000305	0.000872	CcSEcCtD
Tetrabenazine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000305	0.000871	CcSEcCtD
Tetrabenazine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000304	0.000869	CcSEcCtD
Tetrabenazine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000304	0.000868	CcSEcCtD
Tetrabenazine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000297	0.000849	CcSEcCtD
Tetrabenazine—Dizziness—Metformin—type 2 diabetes mellitus	0.000297	0.000848	CcSEcCtD
Tetrabenazine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000295	0.000842	CcSEcCtD
Tetrabenazine—Nausea—Valsartan—type 2 diabetes mellitus	0.000293	0.000837	CcSEcCtD
Tetrabenazine—Constipation—Ramipril—type 2 diabetes mellitus	0.000292	0.000835	CcSEcCtD
Tetrabenazine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.00029	0.000828	CcSEcCtD
Tetrabenazine—Nausea—Orlistat—type 2 diabetes mellitus	0.000289	0.000827	CcSEcCtD
Tetrabenazine—Asthenia—Losartan—type 2 diabetes mellitus	0.000286	0.000817	CcSEcCtD
Tetrabenazine—Vomiting—Metformin—type 2 diabetes mellitus	0.000285	0.000816	CcSEcCtD
Tetrabenazine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000282	0.000805	CcSEcCtD
Tetrabenazine—Headache—Metformin—type 2 diabetes mellitus	0.000281	0.000804	CcSEcCtD
Tetrabenazine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00028	0.000801	CcSEcCtD
Tetrabenazine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000273	0.00078	CcSEcCtD
Tetrabenazine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.00027	0.000772	CcSEcCtD
Tetrabenazine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000269	0.00077	CcSEcCtD
Tetrabenazine—Nausea—Metformin—type 2 diabetes mellitus	0.000266	0.000762	CcSEcCtD
Tetrabenazine—Headache—Irbesartan—type 2 diabetes mellitus	0.000265	0.000758	CcSEcCtD
Tetrabenazine—CYP2D6—kidney—type 2 diabetes mellitus	0.000264	0.0265	CbGeAlD
Tetrabenazine—Dizziness—Losartan—type 2 diabetes mellitus	0.000263	0.000753	CcSEcCtD
Tetrabenazine—Vomiting—Losartan—type 2 diabetes mellitus	0.000253	0.000724	CcSEcCtD
Tetrabenazine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000251	0.000719	CcSEcCtD
Tetrabenazine—Headache—Losartan—type 2 diabetes mellitus	0.00025	0.000714	CcSEcCtD
Tetrabenazine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000245	0.000701	CcSEcCtD
Tetrabenazine—Nausea—Losartan—type 2 diabetes mellitus	0.000237	0.000677	CcSEcCtD
Tetrabenazine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.000234	0.000668	CcSEcCtD
Tetrabenazine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000226	0.000646	CcSEcCtD
Tetrabenazine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000217	0.000621	CcSEcCtD
Tetrabenazine—Headache—Ramipril—type 2 diabetes mellitus	0.000214	0.000612	CcSEcCtD
Tetrabenazine—Nausea—Ramipril—type 2 diabetes mellitus	0.000203	0.00058	CcSEcCtD
Tetrabenazine—CYP2D6—liver—type 2 diabetes mellitus	0.000167	0.0167	CbGeAlD
Tetrabenazine—CBR1—Metabolism—CALM1—type 2 diabetes mellitus	9.26e-05	0.000545	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—PPARG—type 2 diabetes mellitus	9.25e-05	0.000544	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—APOE—type 2 diabetes mellitus	9.23e-05	0.000543	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—type 2 diabetes mellitus	9.16e-05	0.000539	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—APOA1—type 2 diabetes mellitus	9.12e-05	0.000536	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	9.07e-05	0.000533	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—MC4R—type 2 diabetes mellitus	9.06e-05	0.000533	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GIP—type 2 diabetes mellitus	8.72e-05	0.000513	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—GCG—type 2 diabetes mellitus	8.62e-05	0.000507	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GSTM1—type 2 diabetes mellitus	8.53e-05	0.000501	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	8.41e-05	0.000495	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—SERPINE1—type 2 diabetes mellitus	8.33e-05	0.00049	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—type 2 diabetes mellitus	8.19e-05	0.000482	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—ADRB3—type 2 diabetes mellitus	8.17e-05	0.00048	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PPARG—type 2 diabetes mellitus	8.04e-05	0.000473	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—type 2 diabetes mellitus	8e-05	0.000471	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CRHR1—type 2 diabetes mellitus	7.89e-05	0.000464	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—INS—type 2 diabetes mellitus	7.88e-05	0.000464	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—type 2 diabetes mellitus	7.6e-05	0.000447	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—GNB3—type 2 diabetes mellitus	7.43e-05	0.000437	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—ADRB3—type 2 diabetes mellitus	7.42e-05	0.000436	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MTNR1A—type 2 diabetes mellitus	7.37e-05	0.000433	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—AVP—type 2 diabetes mellitus	7.33e-05	0.000431	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—ALB—type 2 diabetes mellitus	7.23e-05	0.000425	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—MTNR1B—type 2 diabetes mellitus	7.22e-05	0.000424	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	7.18e-05	0.000422	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CRHR1—type 2 diabetes mellitus	7.16e-05	0.000421	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—GLP1R—type 2 diabetes mellitus	7.03e-05	0.000413	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—EDN1—type 2 diabetes mellitus	6.98e-05	0.00041	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CCKAR—type 2 diabetes mellitus	6.92e-05	0.000407	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3R1—type 2 diabetes mellitus	6.91e-05	0.000407	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—NOS3—type 2 diabetes mellitus	6.91e-05	0.000407	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—MTNR1B—type 2 diabetes mellitus	6.55e-05	0.000385	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—BHMT—type 2 diabetes mellitus	6.5e-05	0.000382	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GLP1R—type 2 diabetes mellitus	6.39e-05	0.000375	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GCGR—type 2 diabetes mellitus	6.36e-05	0.000374	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PTGS2—type 2 diabetes mellitus	6.32e-05	0.000372	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CCKAR—type 2 diabetes mellitus	6.28e-05	0.000369	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	6.26e-05	0.000368	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—CCR5—type 2 diabetes mellitus	6.24e-05	0.000367	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	6.23e-05	0.000366	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—C3—type 2 diabetes mellitus	6.09e-05	0.000358	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	6.08e-05	0.000358	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	6.05e-05	0.000356	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GRK5—type 2 diabetes mellitus	5.85e-05	0.000344	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GIPR—type 2 diabetes mellitus	5.85e-05	0.000344	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	5.79e-05	0.000341	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—AGT—type 2 diabetes mellitus	5.79e-05	0.00034	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AANAT—type 2 diabetes mellitus	5.68e-05	0.000334	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PTGDS—type 2 diabetes mellitus	5.68e-05	0.000334	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IAPP—type 2 diabetes mellitus	5.66e-05	0.000333	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	5.62e-05	0.000331	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	5.52e-05	0.000325	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	5.49e-05	0.000323	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	5.47e-05	0.000322	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CDO1—type 2 diabetes mellitus	5.39e-05	0.000317	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GPD2—type 2 diabetes mellitus	5.39e-05	0.000317	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MC4R—type 2 diabetes mellitus	5.35e-05	0.000315	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	5.35e-05	0.000315	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	5.33e-05	0.000313	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	5.26e-05	0.00031	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	5.26e-05	0.000309	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GIP—type 2 diabetes mellitus	5.15e-05	0.000303	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AK1—type 2 diabetes mellitus	5.14e-05	0.000302	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	5.1e-05	0.0003	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	4.97e-05	0.000292	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—LEPR—type 2 diabetes mellitus	4.9e-05	0.000288	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—GCG—type 2 diabetes mellitus	4.87e-05	0.000287	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	4.86e-05	0.000286	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GHRL—type 2 diabetes mellitus	4.84e-05	0.000285	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	4.79e-05	0.000282	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CALCA—type 2 diabetes mellitus	4.78e-05	0.000281	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—CCL2—type 2 diabetes mellitus	4.77e-05	0.00028	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC5A4—type 2 diabetes mellitus	4.74e-05	0.000279	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MAT1A—type 2 diabetes mellitus	4.74e-05	0.000279	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	4.68e-05	0.000275	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HBA2—type 2 diabetes mellitus	4.58e-05	0.000269	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—G6PC—type 2 diabetes mellitus	4.58e-05	0.000269	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PPP1R3C—type 2 diabetes mellitus	4.58e-05	0.000269	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ENPP1—type 2 diabetes mellitus	4.58e-05	0.000269	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ND1—type 2 diabetes mellitus	4.58e-05	0.000269	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TLE4—type 2 diabetes mellitus	4.55e-05	0.000268	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GCGR—type 2 diabetes mellitus	4.44e-05	0.000261	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GCG—type 2 diabetes mellitus	4.43e-05	0.00026	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	4.38e-05	0.000258	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	4.35e-05	0.000256	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	4.23e-05	0.000249	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	4.2e-05	0.000247	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—OXCT1—type 2 diabetes mellitus	4.19e-05	0.000246	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYTB—type 2 diabetes mellitus	4.19e-05	0.000246	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—AVP—type 2 diabetes mellitus	4.14e-05	0.000244	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SRD5A1—type 2 diabetes mellitus	4.08e-05	0.00024	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—IL6—type 2 diabetes mellitus	3.96e-05	0.000233	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	3.94e-05	0.000232	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	3.91e-05	0.00023	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HSD17B3—type 2 diabetes mellitus	3.9e-05	0.000229	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ACACA—type 2 diabetes mellitus	3.9e-05	0.000229	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—STAR—type 2 diabetes mellitus	3.9e-05	0.000229	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	3.87e-05	0.000228	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	3.87e-05	0.000228	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—GNB3—type 2 diabetes mellitus	3.81e-05	0.000224	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RBP4—type 2 diabetes mellitus	3.77e-05	0.000222	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	3.77e-05	0.000222	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—MMP3—type 2 diabetes mellitus	3.76e-05	0.000221	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—AVP—type 2 diabetes mellitus	3.76e-05	0.000221	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	3.74e-05	0.00022	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ABCC8—type 2 diabetes mellitus	3.73e-05	0.00022	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CBS—type 2 diabetes mellitus	3.73e-05	0.00022	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	3.71e-05	0.000218	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—COX2—type 2 diabetes mellitus	3.6e-05	0.000211	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC5A2—type 2 diabetes mellitus	3.6e-05	0.000211	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—EDN1—type 2 diabetes mellitus	3.58e-05	0.00021	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NCOA6—type 2 diabetes mellitus	3.53e-05	0.000208	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	3.52e-05	0.000207	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HSD11B1—type 2 diabetes mellitus	3.47e-05	0.000204	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—UCP3—type 2 diabetes mellitus	3.47e-05	0.000204	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—UCP2—type 2 diabetes mellitus	3.47e-05	0.000204	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—C3—type 2 diabetes mellitus	3.44e-05	0.000202	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	3.4e-05	0.0002	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	3.36e-05	0.000198	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IAPP—type 2 diabetes mellitus	3.34e-05	0.000196	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—INSR—type 2 diabetes mellitus	3.32e-05	0.000195	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	3.27e-05	0.000192	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PCK1—type 2 diabetes mellitus	3.26e-05	0.000192	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	3.26e-05	0.000192	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	3.26e-05	0.000192	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	3.24e-05	0.000191	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	3.2e-05	0.000188	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—AKT1—type 2 diabetes mellitus	3.18e-05	0.000187	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—C3—type 2 diabetes mellitus	3.13e-05	0.000184	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	3.11e-05	0.000183	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HK1—type 2 diabetes mellitus	3.06e-05	0.00018	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	3.02e-05	0.000178	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	3.02e-05	0.000177	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	3.02e-05	0.000177	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—AGT—type 2 diabetes mellitus	2.97e-05	0.000175	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—KCNJ11—type 2 diabetes mellitus	2.95e-05	0.000174	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GCKR—type 2 diabetes mellitus	2.95e-05	0.000174	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HSD3B2—type 2 diabetes mellitus	2.95e-05	0.000174	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—LPA—type 2 diabetes mellitus	2.95e-05	0.000174	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	2.93e-05	0.000173	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	2.92e-05	0.000172	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CYBA—type 2 diabetes mellitus	2.92e-05	0.000172	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	2.87e-05	0.000169	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GHRL—type 2 diabetes mellitus	2.86e-05	0.000168	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PLAT—type 2 diabetes mellitus	2.86e-05	0.000168	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ALDOB—type 2 diabetes mellitus	2.83e-05	0.000166	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CALCA—type 2 diabetes mellitus	2.82e-05	0.000166	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	2.75e-05	0.000161	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	2.66e-05	0.000156	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	2.65e-05	0.000156	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	2.63e-05	0.000155	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GCG—type 2 diabetes mellitus	2.61e-05	0.000154	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	2.61e-05	0.000154	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	2.57e-05	0.000151	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	2.56e-05	0.000151	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	2.46e-05	0.000144	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	2.45e-05	0.000144	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	2.41e-05	0.000142	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	2.41e-05	0.000142	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	2.4e-05	0.000141	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	2.4e-05	0.000141	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	2.36e-05	0.000139	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	2.35e-05	0.000138	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	2.35e-05	0.000138	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	2.35e-05	0.000138	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	2.33e-05	0.000137	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	2.29e-05	0.000135	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	2.27e-05	0.000134	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	2.26e-05	0.000133	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GNB3—type 2 diabetes mellitus	2.25e-05	0.000133	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AVP—type 2 diabetes mellitus	2.22e-05	0.000131	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MMP3—type 2 diabetes mellitus	2.22e-05	0.000131	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IGF2—type 2 diabetes mellitus	2.21e-05	0.00013	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	2.2e-05	0.00013	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	2.18e-05	0.000128	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—APOB—type 2 diabetes mellitus	2.15e-05	0.000126	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	2.14e-05	0.000126	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EDN1—type 2 diabetes mellitus	2.11e-05	0.000124	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	2.1e-05	0.000124	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	2.1e-05	0.000124	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	2.1e-05	0.000124	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	2.06e-05	0.000121	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—LPL—type 2 diabetes mellitus	2.05e-05	0.000121	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	2.05e-05	0.00012	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	2.01e-05	0.000118	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	2e-05	0.000118	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	1.92e-05	0.000113	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	1.92e-05	0.000113	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	1.9e-05	0.000112	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	1.9e-05	0.000112	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCR5—type 2 diabetes mellitus	1.89e-05	0.000111	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	1.86e-05	0.000109	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—C3—type 2 diabetes mellitus	1.85e-05	0.000109	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	1.82e-05	0.000107	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	1.82e-05	0.000107	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.76e-05	0.000104	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.76e-05	0.000103	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AGT—type 2 diabetes mellitus	1.76e-05	0.000103	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.73e-05	0.000101	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—LEP—type 2 diabetes mellitus	1.72e-05	0.000101	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—APOE—type 2 diabetes mellitus	1.72e-05	0.000101	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.7e-05	0.0001	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.62e-05	9.54e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.57e-05	9.24e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	1.57e-05	9.24e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	1.56e-05	9.2e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	1.54e-05	9.08e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.53e-05	9.02e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	1.5e-05	8.81e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—INS—type 2 diabetes mellitus	1.47e-05	8.64e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	1.46e-05	8.57e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.45e-05	8.5e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.43e-05	8.42e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.42e-05	8.36e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.42e-05	8.35e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.41e-05	8.32e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.4e-05	8.24e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.4e-05	8.21e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.36e-05	8e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.35e-05	7.94e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.34e-05	7.9e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.29e-05	7.58e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.29e-05	7.58e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.29e-05	7.58e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.26e-05	7.43e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.22e-05	7.2e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.21e-05	7.13e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.2e-05	7.08e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.2e-05	7.05e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.19e-05	6.97e-05	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.1e-05	6.49e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.09e-05	6.43e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.09e-05	6.39e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.04e-05	6.15e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.03e-05	6.08e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.02e-05	6.03e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.02e-05	6.01e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1e-05	5.9e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SRC—type 2 diabetes mellitus	9.53e-06	5.6e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	9.4e-06	5.53e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	9.28e-06	5.46e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	8.99e-06	5.29e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	8.99e-06	5.29e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	8.52e-06	5.01e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EGFR—type 2 diabetes mellitus	8.35e-06	4.91e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	8.22e-06	4.83e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL6—type 2 diabetes mellitus	6.42e-06	3.78e-05	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.92e-06	3.48e-05	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	4.13e-06	2.43e-05	CbGpPWpGaD
